Top compounds associated with response to EVC2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA importazole CTRPv2 pan-cancer AAC 0.014 0.7
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.017 0.7
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA Axitinib GDSC1000 pan-cancer AAC -0.012 0.7
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA CIL70 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA LAQ824 GDSC1000 pan-cancer AAC 0.011 0.7
Download CSV